Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Hospital Regional Universitario de Málaga
Málaga, EspañaPublications in collaboration with researchers from Hospital Regional Universitario de Málaga (3)
2021
-
OX40 agonist BMS-986178 alone or in combination with nivolumab and/or ipilimumab in patients with advanced solid tumors
Clinical Cancer Research, Vol. 27, Núm. 2, pp. 460-472
2009
2001
-
High-dose mitoxantrone and cyclophosphamide without stem cell support in patients with high-risk and advanced breast carcinoma: A Phase II multicentric trial
Cancer, Vol. 92, Núm. 10, pp. 2508-2516